Fig. 4.
Fig. 4. Cumulative incidence of relapse (CIR) of AML patients categorized into favorable, intermediate, and adverse cytogenetic risk groups using the CALGB criteria.

Cumulative incidence of relapse (CIR) of AML patients categorized into favorable, intermediate, and adverse cytogenetic risk groups using the CALGB criteria.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal